Search

everythinglearnresearchcommunity

for

Search:↓

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Pantothenic acid helps mink hair follicles grow by affecting certain cell signals.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Beard hair follicles have more androgen receptors than non-balding scalp hair follicles.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

Overweight women with PCOS are more likely to have excess male hormones.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Lowering certain hormone levels improves treatment for hair loss in young men.

Low estrogen compared to androgen may cause female hair loss.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Higher androgen levels during puberty are linked to shorter adult height in boys with Silver-Russell syndrome.

Two new mutations in the AR gene linked to severe androgen insensitivity were found.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

High androgen levels and genetic factors likely cause Becker's nevus and related symptoms.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.